Identification of iduronate sulfatase gene alterations in 70 unrelated Hunter patients

Clinical Genetics

Volumn 53, Issue 5, 1998, Pages 362-368

  Froissart, Roseline ^a   Maire, Irène ^a   Millat, Gilles ^a   Cudry, Stéphane ^a   Birot, Anne Marie ^a   Bonnet, Véronique ^a   Bouton, Olivier ^a   Bozon, Dominique ^a  

^a HÔPITAL DEBROUSSE   (France)

Author keywords

Iduronate 2 sulfatase; MPS II; Mutations; Rearrangements

Indexed keywords

IDURONATE 2 SULFATASE;

ARTICLE; GENE DELETION; GENE INSERTION; GENE REARRANGEMENT; HETEROZYGOTE DETECTION; HUMAN; HUNTER SYNDROME; MAJOR CLINICAL STUDY; NONSENSE MUTATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL;

EID: 0031744663     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0004.1998.tb02746.x     Document Type: Article

References (44)

1. Neufeld EF, Muenzer J. The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease, 7th edn. New York: McGraw-Hill, 1995: 2465-2494.
2. Wilson PJ, Morris DS, Anson DS, Occhiodoro T, Bielicki J, Clements PR, Hopwood JJ. Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA. Proc Natl Acad Sci USA 1990: 87: 8531-8535.
3. Wilson PJ, Meaney CA, Hopwood JJ, Morris CP. Sequence of the iduronate-2-sulfatase (IDS) gene. Genomics 1993: 17: 773-775.
4. Bondeson ML, Malmgren H, Dahl N, Carlberg BM, Pettersson U. The presence of an IDS-related locus (IDS2) in Xq28 complicates the mutational analysis of Hunter syndrome. Eur J Hum Genet 1995: 3: 219-227.
5. Rathmann M, Bunge S, Steglich C, Schwinger E, Gal A, Evidence for an iduronate-sulfatase pseudogene near the functional Hunter syndrome gene in Xq27.3-q28. Hum Genet 1995: 95: 34-38.
6. Timms KM, Lu F, Shen Y, Pierson CA, Muzny DM, Gu Y, Nelson DL, Gibbs RA. 130 kb of DNA sequence reveals two new genes and a regional duplication distal to the human iduronate-2-sulfate sulfatase locus. Genome Res 1995: 5: 71-78.
7. Goldenfum SL, Young E, Michelakakis H, Tsagarakis S Winchester B. Mutation analysis in 20 patients with Hunter disease. Hum Mutat 1996: 7: 76-78.
8. Hopwood JJ, Bunge S, Morris CP, Wilson PJ, Steglich C, Beck M, Schwinger E, Gal A. Molecular basis of mucopolysaccharidosis type II: mutations in the iduronate-2-sulphatase gene. Hum Mutat 1993: 2: 435-442.
9. Olsen TC, Eiken HG, Knappskog PM, Kase BF, Mansson JE, Boman H, Apold J. Mutation in the iduronate-2-sulfatase gene in five Norwegians with Hunter syndrome. Hum Genet 1996: 97: 198-203.
10. Rathmann M, Bunge S, Beck M, Kresse H, Tylki-Szymanska A, Gal A. Mucopolyaccharidosis type II (Hunter syndrome): mutation "hot spots" in the iduronate-2-sulfatase gene. Am J Hum Genet 1996: 59: 1202-1209.
11. Froissart R, Maire I, Bonnet V, Levade T, Bozon D. Germline and somatic mosaicism in a female carrier of Hunter disease. J Med Genet 1997: 34: 137-140.
12. Froissart R, Blond JL, Maire I, Guibaud P, Hopwood JJ, Mathieu M, Bozon D. Hunter syndrome: gene deletions and rearrangements. Hum Mutat 1993: 2: 138-140.
13. Birot AM, Delobel B, Gronnier P, Bonnet V, Maire I, Bozon D. A 5-Megabase familial deletion removes the IDS and FMR-1 genes in a male Hunter patient. Hum Mutat 1996: 7: 266-268.
14. Birot AM, Bouton O, Froissart R, Maire I, Bozon D. IDS gene-pseudogene exchange responsible for an intragenic deletion in a Hunter patient. Hum Mutat 1996: 8: 44-50.
15. Bondeson ML, Dahl N, Malmgren H, Kleijer WJ, Tönnesen T, Carlberg BM, Pettersson U. Inversion of the IDS gene resulting from recombination with IDS-related sequences is a common cause of the Hunter syndrome. Hum Mol Genet 1995: 4: 615-621.
16. Lagerstedt K, Karsten SL, Carlberg BM, Kleijer WJ, Tönnesen T, Pettersson U, Bondeson ML. Double-strand breaks may initiate the inversion mutation causing the Hunter syndrome. Hum Mol Genet 1997: 6: 627-633.
17. Palmieri G, Capra V, Romano G, D'Urso M, Johnson S, Schlessinger D, Morris P, Hopwood J, Di Natale P, Gatti R, Ballabio A. The iduronate sulfatase gene: isolation of a 1.2-Mb YAC contig spanning the entire gene and identification of heterogeneous deletions in patients with hunter syndrome. Genomics 1992: 12: 52-57.
18. Karsten S, Lagerstedt K, Carlberg BM, Kleijer WJ, Zaremba J, Van Diggelen OP, Czartoryska B, Pettersson U, Bondeson ML. Two distinct deletions in the IDS gene and the W gene: a novel type of mutation associated with the Hunter syndrome. Genomics 1997: 43: 123-129.
19. Bunge S, Steglich C, Zuther C, Beck M, Morris CP, Schwinger E, Schinzel A, Hopwood JJ, Gal A. Iduronate-2-sulfatase gene mutations in 16 patients with mucopolysaccharidosis type II (hunter syndrome). Hum Mol Genet 1993: 2: 1871-1875.
20. Robberson BL, Cote GJ, Berget SM. Exon definition may facilitate splice site selection in RNAs with multiple exons. Mol Cell Biol 1990: 10: 84-94.
21. +1 to t substitution in a 5′-splice site causing Fabry disease. Genomics 1992: 12: 643-650.
22. Millat G, Froissart R, Maire I, Bozon D. Characterization of IDS mutants affecting N-glycosylation sites and the 84 cysteine residue. Biochem J 1997: 326: 243-247.
23. Sukegawa K, Tomatsu S, Fukao T, Iwata H, Song XQ, Yamada Y, Fukuda S, Isogai K, Orii T. Mucopolysaccharidosis type II (Hunter disease): identification and characterization of eight point mutations in the iduronate-2-sulfatase gene in Japanese patients. Hum Mutat 1995: 6: 136-143.
24. Crotty PL, Braun SE, Anderson RA, Whitley CB. Mutation R468W of the iduronate-2-sulfatase gene in mild Hunter syndrome (mucopolysaccharidosis type II) confirmed by in vitro mutagenesis and expression. Hum Mol Genet 1992: 1: 755-757.
25. Millat G, Froissart R, Cudry S, Bonnet V, Maire I, Bozon D. Functional characterization of four missense mutations causing Hunter disease. BBA 1998 (in press).
26. Froissart R, Millat G, Mathieu M, Bozon D, Maire I. Processing of iduronate 2-sulphatase in human fibroblasts. Biochem J 1995: 309: 425-430.
27. Millat G, Froissart R, Maire I, Bozon D. IDS transfer from overexpressing cells to IDS-deficient cells. Exp Cell Res 1997: 230: 362-367.
28. Franco B, Meroni G, Parenti G, Levilliers J, Bernard L, Gebbia M, Cox L, Maroteaux P, Sheffield L, Rappold GA, Andrea G, Petit C, Ballabio A. A cluster of sulfatase genes on Xp22.3: mutations in chondrodysplasia punctata (CDPX) and implications for Warfarin embryopathy. Cell 1995: 81: 15-25.
29. Schmidt B, Selmer T, Ingendoh A, von Figura K. A novel amino acid modification in sulfatases that is defective in multiple sulfatase deficiency. Cell 1995: 82: 272-278.
30. Bakker E, Veenema H, den Dunnen JT, van Broeckhoven C, Grootscholten PM, Bonten EJ, van Ommen GJB, Pearson PL. Germinal mosaicism increases the recurrence risk for 'new' Duchenne muscular dystrophy mutations. J Med Genet 1989: 26: 553-559.
31. Gitschier J, Levinson B, Lehesjoki AE, de la Chapelle A. Mosaicism and sporadic haemophilia: implications for carrier detection. Lancet 1989: i: 273-274.
32. Wilton SD, Chandler DC, Kakulas BA, Laing NG. Identification of a point mutation and germinal mosaicism in a Duchenne muscular dystrophy family. Hum Mutat 1994: 3: 133-140.
33. Grimm T, Meng G, Liechti-Gallati S, Bettecken T, Müller CR, Müller B. On the origin of deletions and point mutations in Duchenne muscular dystrophy: most deletions arise in oogenesis and most point mutations result from events in spermatogenesis. J Med Genet 1996: 31: 183-186.
34. Grimm T, Olek K, Oldenburg J. Characterization of the factor VIII defect in 147 patients with sporadic hemophilia A: family studies indicate a mutation type-dependent sex ratio of mutation frequencies. Am J Hum Genet 1996b: 58: 657-670.
35. Popowska E, Rathmann M, Tylki-Szymanska A, Bunge S, Steglich C, Schwinger E, Gal A. Mutations of the iduronate-2-sulfatase gene in 12 Polish patients with mucopolysaccharidosis type II (Hunter syndrome). Hum Mutat 1995: 5: 97-100.
36. Flomen RH, Green PM, Bentley DR, Giannelli F, Green EP. Detection of point mutations and a gross deletion in six Hunter syndrome patients. Genomics 1992: 13: 543-550.
37. Li P, Thompson N. Detection of four novel mutations in the iduronate-2-sulphatase gene by single-strand conformation polymorphism analysis of genomic amplicons. J Inher Metab Dis 1996: 19: 93-94.
38. Bunge S, Steglich C, Beck M, Rosenkranz W, Schwinger E, Hopwood JJ, Gal A. Mutation analysis of the iduronate-2-sulfatase gene in patients with mucopolysacccharidosis type II (Hunter syndrome). Hum Mol Genet 1992: 1: 335-339.
39. 1327 to T substitution in the iduronate sulfatase gene. Biochem Biophys Res Commun 1992: 183: 809-813.
40. Schröder W, Wulff K, Wehnert M, Seidlitz G, Herrmann FH. Mutations of the iduronate-2-sulfatase (IDS) gene in patients with Hunter syndrome (mucopolysaccharidosis II). Hum Mutat 1994: 4: 128-131.
41. Li P, Huffman P, Thompson JN. Mutations of the iduronate-2-sulfatase gene on a T146T background in three patients with Hunter syndrome. Hum Mutat 1995: 5: 272-274.
42. Villani GRD, Balzano N, Grosso M, Salvatore F, Izzo P, Di Natale P. Mucopolysaccharidosis type II: identification of six novel mutations in Italian patients. Hum Mutat 1997: 10: 71-75.
43. Whitley CB, Anderson RA, Aronovich EL, Crotty PL, Anyane-Yeboa K, Russo D, Warburton D. Caveat to genotype-phenotype correlation in mucopolysaccharidosis type II: discordant clinical severity of R468W and R468Q mutations of the iduronate-2-sulfatase gene. Hum Mutat 1993: 2: 235-237.
44. Li P, Moore JF, Thompson JN. Novel use of limited primer extension in detecting mutations in human iduronate 2-sulfatase gene. Biochem Mol Biol Int 1995: 35: 1299-1305.